Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Pouget, ER AU - Hagan, H AU - Des Jarlais, DC TI - Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment J2 - Addiction PY - 2012 VL - 107 SP - 1057 EP - 1065 UR - http://dx.doi.org/10.1111/j.1360-0443.2011.03765.x ER - TY - JOUR LB - 2. AU - Strathdee, SA AU - Hallett, TB AU - Bobrova, N AU - Rhodes, T AU - Booth, R AU - Abdool, R AU - Hankins, CA TI - HIV and risk environment for injecting drug users: the past, present, and future J2 - Lancet PY - 2010 VL - 376 SP - 268 EP - 284 UR - http://dx.doi.org/10.1016/S0140-6736(10)60743-X ER - TY - JOUR LB - 3. AU - Palmateer, N AU - Kimber, J AU - Hickman, M AU - Hutchinson, S AU - Rhodes, T AU - Goldberg, D TI - Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews J2 - Addiction PY - 2010 VL - 105 SP - 844 EP - 859 UR - http://dx.doi.org/10.1111/j.1360-0443.2009.02888.x ER - TY - BOOK LB - 4. AU - NICE TI - Needle and Syringe Programmes (2009) CY - London PB - NICE PY - 2014 ER - TY - JOUR LB - 5. AU - Bluthenthal, RN AU - Anderson, R AU - Flynn, NM AU - Kral, AH TI - Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients J2 - Drug Alcohol Depend PY - 2007 VL - 89 SP - 214 EP - 222 UR - https://doi.org/10.1016/j.drugalcdep.2006.12.035 ER - TY - JOUR LB - 6. AU - Kaplan, EH AU - Heimer, R TI - A model-based estimate of HIV infectivity via needle sharing J2 - J Acquir Immune Defic Syndr PY - 1992 VL - 5 SP - 1116 EP - 1118 ER - TY - BOOK LB - 7. AU - Tilson, H AU - Aramrattana, A AU - Bozzette, SA TI - Preventing HIV Infection Among Injecting Drug Users in High-risk Countries: An Assessment of the Evidence CY - Washington, DC PB - Institute of Medicine PY - 2007 ER - TY - JOUR LB - 8. AU - Gowing, L AU - Farrell, MF AU - Bornemann, R AU - Sullivan, LE AU - Ali, R TI - Oral substitution treatment of injecting opioid users for prevention of HIV infection J2 - Cochrane Database Syst Rev PY - 2011 VL - 8 SP - CD004145 UR - http://dx.doi.org/10.1002/14651858.CD004145.pub4 ER - TY - JOUR LB - 9. AU - Vorma, H AU - Sokero, P AU - Aaltonen, M AU - Turtiainen, S AU - Hughes, LA AU - Savolainen, J TI - Participation in opioid substitution treatment reduces the rate of criminal convictions: evidence from a community study J2 - Addict Behav PY - 2013 VL - 38 SP - 2313 EP - 2316 UR - http://dx.doi.org/10.1016/j.addbeh.2013.03.009 ER - TY - JOUR LB - 10. AU - Amato, L AU - Davoli, M AU - Minozzi, S AU - Ferroni, E AU - Ali, R AU - Ferri, M TI - Methadone at tapered doses for the management of opioid withdrawal J2 - Cochrane Database Syst Rev PY - 2013 VL - 2 SP - CD003409 UR - http://dx.doi.org/10.1002/14651858.CD003409.pub4 ER - TY - JOUR LB - 11. AU - Faggiano, F AU - Vigna-Taglianti, F AU - Versino, E AU - Lemma, P TI - Methadone maintenance at different dosages for opioid dependence J2 - Cochrane Database Syst Rev PY - 2003 VL - 3 SP - CD002208 UR - http://dx.doi.org/10.1002/14651858.CD002208 ER - TY - JOUR LB - 12. AU - Gibson, DR AU - Flynn, NM AU - McCarthy, JJ TI - Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users J2 - AIDS PY - 1999 VL - 13 SP - 1807 EP - 1818 UR - https://doi.org/10.1097/00002030-199910010-00002 ER - TY - BOOK LB - 13. AU - Jones, L AU - Pickering, L AU - Sumnall, H AU - McVeigh, J AU - Bellis, MA TI - A Review of the Effectiveness and Cost-effectiveness of Needle and Syringe Programmes for Injecting Drug Users CY - Liverpool PB - Centre for Public Health, Liverpool John Moores University PY - 2008 ER - TY - JOUR LB - 14. AU - Van Den Berg, C AU - Smit, C AU - Van Brussel, G AU - Coutinho, R AU - Prins, M AU - Amsterdam Cohort TI - Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users J2 - Addiction PY - 2007 VL - 102 SP - 1454 EP - 1462 UR - https://doi.org/10.1111/j.1360-0443.2007.01912.x ER - TY - JOUR LB - 15. AU - Gibson, DR AU - Flynn, NM AU - Perales, D TI - Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users J2 - AIDS PY - 2001 VL - 15 SP - 1329 EP - 1341 UR - https://doi.org/10.1097/00002030-200107270-00002 ER - TY - JOUR LB - 16. AU - Aspinall, E AU - Nambiar, D AU - Goldberg, DJ AU - Hickman, M AU - Weir, A AU - Van Velzen, E TI - Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis J2 - Int J Epidemiol PY - 2014 VL - 43 SP - 235 EP - 248 UR - https://doi.org/10.1093/ije/dyt243 ER - TY - JOUR LB - 17. AU - MacArthur, GJ AU - Minozzi, S AU - Martin, N AU - Vickerman, P AU - Deren, S AU - Bruneau, J TI - Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis J2 - BMJ PY - 2012 VL - 345 SP - e5945 UR - http://dx.doi.org/10.1136/bmj.e5945 ER - TY - BOOK LB - 18. AU - Wodak, A AU - Cooney, A TI - Effectiveness of Sterile Needle and Syringe Programming in Reducing HIV/AIDS Among Injecting Drug Users CY - Geneva PB - WHO PY - 2004 ER - TY - JOUR LB - 19. AU - Hagan, H AU - Pouget, ER AU - Des Jarlais, DC TI - A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs J2 - J Infect Dis PY - 2011 VL - 204 SP - 74 EP - 83 UR - http://dx.doi.org/10.1093/infdis/jir196 ER - TY - JOUR LB - 20. AU - Turner, KM AU - Hutchinson, S AU - Vickerman, P AU - Hope, V AU - Craine, N AU - Palmateer, N TI - The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence J2 - Addiction PY - 2011 VL - 106 SP - 1978 EP - 1988 UR - http://dx.doi.org/10.1111/j.1360-0443.2011.03515.x ER - TY - BOOK LB - 21. AU - Vickerman, P AU - Miners, A AU - Williams, J TI - Assessing the Cost-effectiveness of Interventions Linked to Needle and Syringe Programmes for Injecting Drug Users: An Economic Modelling Report PB - NICE PY - 2008 UR - www.nice.org.uk/nicemedia/pdf/NSPEconomicmodellingFullreportJune08.pdf Y2 - 1 March 2016 ER - TY - BOOK LB - 22. AU - Committee on the Prevention of HIV infection among Injecting Drug Users in High-Risk Countries TI - Preventing HIV Infection Among Injecting Drug Users in High-Risk Countries: An Assessment of the Evidence CY - Washington, DC PB - Institute of Medicine PY - 2007 ER - TY - JOUR LB - 23. AU - Mathers, BM AU - Degenhardt, L AU - Ali, H AU - Wiessing, L AU - Hickman, M AU - Mattick, RP TI - HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage J2 - Lancet PY - 2010 VL - 375 SP - 1014 EP - 1028 UR - http://dx.doi.org/10.1016/S0140-6736(10)60232-2 ER - TY - JOUR LB - 24. AU - Lurie, P TI - Invited commentary: le mystère de Montréal J2 - Am J Epidemiol PY - 1997 VL - 146 SP - 1003 EP - 1006 UR - https://doi.org/10.1093/oxfordjournals.aje.a009227 ER - TY - JOUR LB - 25. AU - Degenhardt, L AU - Mathers, B AU - Vickerman, P AU - Rhodes, T AU - Latkin, C AU - Hickman, M TI - Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed J2 - Lancet PY - 2010 VL - 376 SP - 285 EP - 301 UR - http://dx.doi.org/10.1016/S0140-6736(10)60742-8 ER - TY - JOUR LB - 26. AU - Platt, L AU - Minozzi, S AU - Reed, J AU - Vickerman, P AU - Hagan, H AU - French, C TI - Needle syringe programmes and opiate substitution therapy for preventing hepatitis C transmission in people who inject drugs [published online ahead of print 18 September 2017] J2 - Cochrane Database Syst Rev PY - 2017 UR - http://dx.doi.org/10.1002/14651858.CD012021 ER - TY - BOOK LB - 27. AU - Platt, L AU - Minozzi, S AU - Reed, J AU - Vickerman, P AU - Hogan, H AU - French, C AU - Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis [published online ahead of print 11 September 2017] TI - Addiction PY - 2017 ER - TY - JOUR LB - 28. AU - Higgins, JP AU - Altman, DG AU - Gøtzsche, PC AU - Jüni, P AU - Moher, D AU - Oxman, AD TI - The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials J2 - BMJ PY - 2011 VL - 343 SP - d5928 UR - http://dx.doi.org/10.1136/bmj.d5928 ER - TY - JOUR LB - 29. AU - Guyatt, G AU - Oxman, AD AU - Akl, EA AU - Kunz, R AU - Vist, G AU - Brozek, J TI - GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables J2 - J Clin Epidemiol PY - 2011 VL - 64 SP - 383 EP - 394 UR - http://dx.doi.org/10.1016/j.jclinepi.2010.04.026 ER - TY - JOUR LB - 30. AU - Guyatt, GH AU - Oxman, AD AU - Vist, GE AU - Kunz, R AU - Falck-Ytter, Y AU - Alonso-Coello, P AU - Schünemann, HJ AU - GRADE Working Group TI - GRADE: an emerging consensus on rating quality of evidence and strength of recommendations J2 - BMJ PY - 2008 VL - 336 SP - 924 EP - 926 UR - http://dx.doi.org/10.1136/bmj.39489.470347.AD ER - TY - JOUR LB - 31. AU - Schünemann, HJ AU - Jaeschke, R AU - Cook, DJ AU - Bria, WF AU - El-Solh, AA AU - Ernst, A TI - An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations J2 - Am J Respir Crit Care Med PY - 2006 VL - 174 SP - 605 EP - 614 UR - https://doi.org/10.1164/rccm.200602-197ST ER - TY - JOUR LB - 32. AU - Atkins, D AU - Best, D AU - Briss, PA AU - Eccles, M AU - Falck-Ytter, Y AU - Flottorp, S TI - Grading quality of evidence and strength of recommendations J2 - BMJ PY - 2004 VL - 328 SP - 1490 EP - 1494 UR - https://doi.org/10.1136/bmj.328.7454.1490 ER - TY - GEN LB - 33. AU - Bruneau, J TI - Analyses Received from Julie Bruneau and her Study Team PY - 2015 ER - TY - GEN LB - 34. AU - Mehta, S TI - Analyses Received from Shruti Mehta and her Study Team PY - 2015 ER - TY - GEN LB - 35. AU - Page, K TI - Analyses Received from Kim Page and her Study Team PY - 2015 ER - TY - GEN LB - 36. AU - Judd, A TI - Data Set Obtained from Ali Judd and Analyses Conducted by the Review Team PY - 2015 ER - TY - JOUR LB - 37. AU - Aitken, CK AU - Agius, PA AU - Higgs, PG AU - Stoové, MA AU - Bowden, DS AU - Dietze, PM TI - The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs J2 - Epidemiol Infect PY - 2017 VL - 145 SP - 796 EP - 801 UR - https://doi.org/10.1017/S0950268816002892 ER - TY - JOUR LB - 38. AU - Maher, L AU - Jalaludin, B AU - Chant, KG AU - Jayasuriya, R AU - Sladden, T AU - Kaldor, JM AU - Sargent, PL TI - Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia J2 - Addiction PY - 2006 VL - 101 SP - 1499 EP - 1508 UR - https://doi.org/10.1111/j.1360-0443.2006.01543.x ER - TY - JOUR LB - 39. AU - Craine, N AU - Hickman, M AU - Parry, JV AU - Smith, J AU - Walker, AM AU - Russell, D TI - Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size J2 - Epidemiol Infect PY - 2009 VL - 137 SP - 1255 EP - 1265 UR - http://dx.doi.org/10.1017/S095026880900212X ER - TY - JOUR LB - 40. AU - Crofts, N AU - Nigro, L AU - Oman, K AU - Stevenson, E AU - Sherman, J TI - Methadone maintenance and hepatitis C virus infection among injecting drug users J2 - Addiction PY - 1997 VL - 92 SP - 999 EP - 1005 UR - https://doi.org/10.1111/j.1360-0443.1997.tb02979.x ER - TY - JOUR LB - 41. AU - Hagan, H AU - Jarlais, DC AU - Friedman, SR AU - Purchase, D AU - Alter, MJ TI - Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program J2 - Am J Public Health PY - 1995 VL - 85 SP - 1531 EP - 1537 UR - https://doi.org/10.2105/AJPH.85.11.1531 ER - TY - JOUR LB - 42. AU - Hagan, H AU - McGough, JP AU - Thiede, H AU - Weiss, NS AU - Hopkins, S AU - Alexander, ER TI - Syringe exchange and risk of infection with hepatitis B and C viruses J2 - Am J Epidemiol PY - 1999 VL - 149 SP - 203 EP - 213 UR - https://doi.org/10.1093/oxfordjournals.aje.a009792 ER - TY - JOUR LB - 43. AU - Holtzman, D AU - Barry, V AU - Ouellet, LJ AU - Des Jarlais, DC AU - Vlahov, D AU - Golub, ET TI - The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994–2004 J2 - Prev Med PY - 2009 VL - 49 SP - 68 EP - 73 UR - http://dx.doi.org/10.1016/j.ypmed.2009.04.014 ER - TY - JOUR LB - 44. AU - Hope, VD AU - Hickman, M AU - Ngui, SL AU - Jones, S AU - Telfer, M AU - Bizzarri, M TI - Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots J2 - J Viral Hepat PY - 2011 VL - 18 SP - 262 EP - 270 UR - http://dx.doi.org/10.1111/j.1365-2893.2010.01297.x ER - TY - JOUR LB - 45. AU - Lucidarme, D AU - Bruandet, A AU - Ilef, D AU - Harbonnier, J AU - Jacob, C AU - Decoster, A TI - Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France J2 - Epidemiol Infect PY - 2004 VL - 132 SP - 699 EP - 708 UR - https://doi.org/10.1017/S095026880400247X ER - TY - JOUR LB - 46. AU - Nolan, S AU - Dias Lima, V AU - Fairbairn, N AU - Kerr, T AU - Montaner, J AU - Grebely, J AU - Wood, E TI - The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users J2 - Addiction PY - 2014 VL - 109 SP - 2053 EP - 2059 UR - http://dx.doi.org/10.1111/add.12682 ER - TY - JOUR LB - 47. AU - Palmateer, N AU - Hutchinson, S AU - McAllister, G AU - Munro, A AU - Cameron, S AU - Goldberg, D AU - Taylor, A TI - Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data J2 - J Viral Hepat PY - 2014 VL - 21 SP - 25 EP - 32 UR - http://dx.doi.org/10.1111/jvh.12117 ER - TY - JOUR LB - 48. AU - Patrick, DM AU - Tyndall, MW AU - Cornelisse, PG AU - Li, K AU - Sherlock, CH AU - Rekart, ML TI - Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection J2 - CMAJ PY - 2001 VL - 165 SP - 889 EP - 895 ER - TY - JOUR LB - 49. AU - Rezza, G AU - Sagliocca, L AU - Zaccarelli, M AU - Nespoli, M AU - Siconolfi, M AU - Baldassarre, C TI - Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence J2 - Scand J Infect Dis PY - 1996 VL - 28 SP - 27 EP - 29 UR - https://doi.org/10.3109/00365549609027145 ER - TY - JOUR LB - 50. AU - Roy, E AU - Alary, M AU - Morissette, C AU - Leclerc, P AU - Boudreau, JF AU - Parent, R TI - High hepatitis C virus prevalence and incidence among Canadian intravenous drug users J2 - Int J STD AIDS PY - 2007 VL - 18 SP - 23 EP - 27 UR - http://dx.doi.org/10.1258/095646207779949880 ER - TY - JOUR LB - 51. AU - Ruan, Y AU - Qin, G AU - Yin, L AU - Chen, K AU - Qian, HZ AU - Hao, C TI - Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study J2 - AIDS PY - 2007 VL - 21 IS - Suppl. 8 SP - 39 EP - 46 UR - http://dx.doi.org/10.1097/01.aids.0000304695.54884.4f ER - TY - JOUR LB - 52. AU - Spittal, PM AU - Pearce, ME AU - Chavoshi, N AU - Christian, WM AU - Moniruzzaman, A AU - Teegee, M AU - Schechter, MT TI - The Cedar Project: high incidence of HCV infections in a longitudinal study of young Aboriginal people who use drugs in two Canadian cities J2 - BMC Public Health PY - 2012 VL - 12 SP - 632 UR - http://dx.doi.org/10.1186/1471-2458-12-632 ER - TY - JOUR LB - 53. AU - Thiede, H AU - Hagan, H AU - Murrill, CS TI - Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area J2 - J Urban Health PY - 2000 VL - 77 SP - 331 EP - 345 UR - https://doi.org/10.1007/BF02386744 ER - TY - JOUR LB - 54. AU - Thorpe, LE AU - Ouellet, LJ AU - Hershow, R AU - Bailey, SL AU - Williams, IT AU - Williamson, J TI - Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment J2 - Am J Epidemiol PY - 2002 VL - 155 SP - 645 EP - 653 UR - https://doi.org/10.1093/aje/155.7.645 ER - TY - JOUR LB - 55. AU - Tsui, JI AU - Evans, JL AU - Lum, PJ AU - Hahn, JA AU - Page, K TI - Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users J2 - JAMA Intern Med PY - 2014 VL - 174 SP - 1974 EP - 1981 UR - http://dx.doi.org/10.1001/jamainternmed.2014.5416 ER - TY - JOUR LB - 56. AU - Vallejo, F AU - Barrio, G AU - Brugal, MT AU - Pulido, J AU - Toro, C AU - Sordo, L TI - High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes J2 - J Epidemiol Community Health PY - 2015 VL - 69 SP - 599 EP - 603 UR - https://doi.org/10.1136/jech-2014-205070 ER - TY - JOUR LB - 57. AU - van Beek, I AU - Dwyer, R AU - Dore, GJ AU - Luo, K AU - Kaldor, JM TI - Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study J2 - BMJ PY - 1998 VL - 317 SP - 433 EP - 437 UR - https://doi.org/10.1136/bmj.317.7156.433 ER - TY - JOUR LB - 58. AU - White, B AU - Dore, GJ AU - Lloyd, AR AU - Rawlinson, WD AU - Maher, L TI - Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study J2 - Med J Aust PY - 2014 VL - 201 SP - 326 EP - 329 UR - https://doi.org/10.5694/mja13.00153 ER - TY - GEN LB - 59. AU - Hope, V TI - Data set obtained from Vivian Hope and analyses conducted by the review team PY - 2015 ER - TY - GEN LB - 60. AU - Maher, L TI - Data set obtained from the International Collaborative of prospective studies of HIV and Hepatitis in IDU and analyses conducted by Meghan Morris PY - 2015 ER - TY - JOUR LB - 61. AU - Gower, E AU - Estes, C AU - Blach, S AU - Razavi-Shearer, K AU - Razavi, H TI - Global epidemiology and genotype distribution of the hepatitis C virus infection J2 - J Hepatol PY - 2014 VL - 61 IS - Suppl. 1 SP - 45 EP - 57 UR - http://dx.doi.org/10.1016/j.jhep.2014.07.027 ER - TY - JOUR LB - 62. AU - Mathers, BM AU - Degenhardt, L AU - Phillips, B AU - Wiessing, L AU - Hickman, M AU - Strathdee, SA TI - Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review J2 - Lancet PY - 2008 VL - 372 SP - 1733 EP - 1745 UR - http://dx.doi.org/10.1016/S0140-6736(08)61311-2 ER - TY - JOUR LB - 63. AU - Platt, L AU - Easterbrook, P AU - Gower, E AU - McDonald, B AU - Sabin, K AU - McGowan, C TI - Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis J2 - Lancet Infect Dis PY - 2016 VL - 16 SP - 797 EP - 808 UR - http://dx.doi.org/10.1016/S1473-3099(15)00485-5 ER - TY - JOUR LB - 64. AU - Wood, E AU - Lloyd-Smith, E AU - Li, K AU - Strathdee, SA AU - Small, W AU - Tyndall, MW TI - Frequent needle exchange use and HIV incidence in Vancouver, Canada J2 - Am J Med PY - 2007 VL - 120 SP - 172 EP - 179 UR - https://doi.org/10.1016/j.amjmed.2006.02.030 ER - TY - JOUR LB - 65. AU - Hagan, H AU - McGough, JP AU - Thiede, H AU - Hopkins, SG AU - Weiss, NS AU - Alexander, ER TI - Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs J2 - J Urban Health PY - 2000 VL - 77 SP - 103 EP - 112 UR - http://dx.doi.org/10.1007/BF02350966 ER - TY - JOUR LB - 66. AU - Vickerman, P AU - Platt, L AU - Jolley, E AU - Rhodes, T AU - Kazatchkine, MD AU - Latypov, A TI - Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modeling J2 - Int J Drug Policy PY - 2014 VL - 25 SP - 1163 EP - 1173 UR - https://doi.org/10.1016/j.drugpo.2014.09.013 ER - TY - JOUR LB - 67. AU - Judd, A AU - Hickman, M AU - Jones, S AU - McDonald, T AU - Parry, JV AU - Stimson, GV AU - Hall, AJ TI - Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study J2 - BMJ PY - 2005 VL - 330 SP - 24 EP - 25 UR - https://doi.org/10.1136/bmj.38286.841227.7C ER - TY - JOUR LB - 68. AU - Palmateer, NE AU - Taylor, A AU - Goldberg, DJ AU - Munro, A AU - Aitken, C AU - Shepherd, SJ TI - Rapid decline in HCV incidence among people who inject drugs associated with national scale-up in coverage of a combination of harm reduction interventions J2 - PLOS ONE PY - 2014 VL - 9 SP - e104515 UR - http://dx.doi.org/10.1371/journal.pone.0104515 ER - TY - BOOK LB - 69. AU - Iversen, J AU - Maher, L TI - NSP Survey National Data Report 1995–2014. Prevalence of HIV, HCV and Injecting and Sexual Behaviour Among Needle and Syringe Program Attendees CY - Sydney, NSW PB - Kirby Institute, University of New South Wales PY - 2015 ER - TY - BOOK LB - 70. AU - Public Health England TI - Shooting Up: Infections Among People who Inject Drugs in the UK CY - London PB - Public Health England PY - 2015 ER - TY - JOUR LB - 71. AU - Judd, A AU - Parry, J AU - Hickman, M AU - McDonald, T AU - Jordan, L AU - Lewis, K TI - Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots J2 - J Med Virol PY - 2003 VL - 71 SP - 49 EP - 55 UR - http://dx.doi.org/10.1002/jmv.10463 ER - TY - JOUR LB - 72. AU - Mellor, J AU - Holmes, EC AU - Jarvis, LM AU - Yap, PL AU - Simmonds, P TI - Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: implications for virus classification. The International HCV Collaborative Study Group J2 - J Gen Virol PY - 1995 VL - 76 SP - 2493 EP - 2507 UR - http://dx.doi.org/10.1099/0022-1317-76-10-2493 ER - TY - JOUR LB - 73. AU - Aceijas, C AU - Hickman, M AU - Donoghoe, MC AU - Burrows, D AU - Stuikyte, R TI - Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia J2 - Addiction PY - 2007 VL - 102 SP - 1244 EP - 1250 UR - https://doi.org/10.1111/j.1360-0443.2007.01848.x ER - TY - JOUR LB - 74. AU - Heimer, R AU - Khoshnood, K AU - Bigg, D AU - Guydish, J AU - Junge, B TI - Syringe use and reuse: effects of syringe exchange programs in four cities J2 - J Acquir Immune Defic Syndr Hum Retrovirol PY - 1998 VL - 18 IS - Suppl. 1 SP - 37 EP - 44 UR - https://doi.org/10.1097/00042560-199802001-00008 ER - TY - JOUR LB - 75. AU - Lewis, JR AU - Sauro, J TI - When 100% really isn’t 100%: improving the accuracy of small-sample estimates of completion rates J2 - J Usability Stud PY - 2010 VL - 1 SP - 136 EP - 150 ER - TY - JOUR LB - 76. AU - Wilson, EB TI - Probable inference, the law of succession, and statistical inference J2 - J Am Stat Assoc PY - 1927 VL - 22 SP - 209 EP - 212 UR - https://doi.org/10.1080/01621459.1927.10502953 ER - TY - JOUR LB - 77. AU - Higgins, JP AU - Thompson, SG TI - Quantifying heterogeneity in a meta-analysis J2 - Stat Med PY - 2002 VL - 21 SP - 1539 EP - 1558 UR - http://dx.doi.org/10.1002/sim.1186 ER - TY - JOUR LB - 78. AU - Guinness, L AU - Vickerman, P AU - Quayyum, Z AU - Foss, A AU - Watts, C AU - Rodericks, A TI - The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh J2 - Addiction PY - 2010 VL - 105 SP - 319 EP - 328 UR - http://dx.doi.org/10.1111/j.1360-0443.2009.02755.x ER - TY - JOUR LB - 79. AU - Kwon, JA AU - Anderson, J AU - Kerr, CC AU - Thein, HH AU - Zhang, L AU - Iversen, J TI - Estimating the cost-effectiveness of needle-syringe programs in Australia J2 - AIDS PY - 2012 VL - 26 SP - 2201 EP - 2210 UR - http://dx.doi.org/10.1097/QAD.0b013e3283578b5d ER - TY - JOUR LB - 80. AU - Bruggmann, P AU - Grebely, J TI - Prevention, treatment and care of hepatitis C virus infection among people who inject drugs J2 - Int J Drug Policy PY - 2015 VL - 26 IS - Suppl. 1 SP - 22 EP - 26 UR - http://dx.doi.org/10.1016/j.drugpo.2014.08.014 ER - TY - BOOK LB - 81. AU - NICE TI - Needle and Syringe Programmes CY - London PB - NICE PY - 2014 ER - TY - BOOK LB - 82. AU - Drummond, M AU - Health Outcomes International TI - Return on Investment in Needle and Syringe Programs in Australia: Report CY - Canberra, ACT PB - Commonwealth Department of Health and Ageing PY - 2002 ER - TY - BOOK LB - 83. AU - WHO TI - Guide to Starting and Managing Needle and Syringe Programmes CY - Geneva PB - WHO PY - 2007 ER - TY - JOUR LB - 84. AU - Hope, VD AU - McVeigh, J AU - Marongiu, A AU - Evans-Brown, M AU - Smith, J AU - Kimergård, A TI - Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study J2 - BMJ Open PY - 2013 VL - 3 SP - e003207 UR - http://dx.doi.org/10.1136/bmjopen-2013-003207 ER - TY - JOUR LB - 85. AU - Aitken, C AU - Delalande, C AU - Stanton, K TI - Pumping iron, risking infection? Exposure to hepatitis C, hepatitis B and HIV among anabolic-androgenic steroid injectors in Victoria, Australia J2 - Drug Alcohol Depend PY - 2002 VL - 65 SP - 303 EP - 308 UR - https://doi.org/10.1016/S0376-8716(01)00174-0 ER - TY - JOUR LB - 86. AU - Vickerman, P AU - Grebely, J AU - Dore, GJ AU - Sacks-Davis, R AU - Page, K AU - Thomas, DL TI - The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design J2 - J Infect Dis PY - 2012 VL - 205 SP - 1342 EP - 1350 UR - http://dx.doi.org/10.1093/infdis/jis213 ER - TY - ELEC LB - 87. AU - Information Services Division Scotland TI - Injecting Equipment Provision in Scotland Survey 2013/14 PY - 2015 UR - www.isdscotland.org/Health-Topics/Drugs-and-Alcohol-Misuse/Publications/2015-06-23/2015-06-23-IEP-Report.pdf M1 - 1 March 2016 ER - TY - JOUR LB - 88. AU - Mills, HL AU - Colijn, C AU - Vickerman, P AU - Leslie, D AU - Hope, V AU - Hickman, M TI - Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK J2 - Drug Alcohol Depend PY - 2012 VL - 126 SP - 324 EP - 332 UR - http://dx.doi.org/10.1016/j.drugalcdep.2012.05.036 ER - TY - JOUR LB - 89. AU - Mills, HL AU - Johnson, S AU - Hickman, M AU - Jones, NS AU - Colijn, C TI - Errors in reported degrees and respondent driven sampling: implications for bias J2 - Drug Alcohol Depend PY - 2014 VL - 142 SP - 120 EP - 126 UR - http://dx.doi.org/10.1016/j.drugalcdep.2014.06.015 ER - TY - JOUR LB - 90. AU - Cullen, KJ AU - Hope, VD AU - Croxford, S AU - Shute, J AU - Ncube, F AU - Parry, JV TI - Factors associated with recently acquired hepatitis C virus infection in people who inject drugs in England, Wales and Northern Ireland: new findings from an unlinked anonymous monitoring survey J2 - Epidemiol Infect PY - 2015 VL - 143 SP - 1398 EP - 1407 UR - http://dx.doi.org/10.1017/S0950268814002040 ER - TY - JOUR LB - 91. AU - Kimber, J AU - Copeland, L AU - Hickman, M AU - Macleod, J AU - McKenzie, J AU - De Angelis, D AU - Robertson, JR TI - Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment J2 - BMJ PY - 2010 VL - 341 SP - c3172 UR - http://dx.doi.org/10.1136/bmj.c3172 ER - TY - JOUR LB - 92. AU - Sutton, AJ AU - Gay, NJ AU - Edmunds, WJ AU - Hope, VD AU - Gill, ON AU - Hickman, M TI - Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales J2 - BMC Infect Dis PY - 2006 VL - 6 SP - 93 UR - https://doi.org/10.1186/1471-2334-6-93 ER - TY - JOUR LB - 93. AU - Shepherd, J AU - Jones, J AU - Hartwell, D AU - Davidson, P AU - Price, A AU - Waugh, N TI - Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation J2 - Health Technol Assess PY - 2007 VL - 11 IS - 11 UR - https://doi.org/10.3310/hta11110 ER - TY - JOUR LB - 94. AU - Bruno, S AU - Zuin, M AU - Crosignani, A AU - Rossi, S AU - Zadra, F AU - Roffi, L TI - Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study J2 - Am J Gastroenterol PY - 2009 VL - 104 SP - 1147 EP - 1158 UR - http://dx.doi.org/10.1038/ajg.2009.31 ER - TY - JOUR LB - 95. AU - Morgan, RL AU - Baack, B AU - Smith, BD AU - Yartel, A AU - Pitasi, M AU - Falck-Ytter, Y TI - Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies J2 - Ann Intern Med PY - 2013 VL - 158 SP - 329 EP - 337 UR - http://dx.doi.org/10.7326/0003-4819-158-5-201303050-00005 ER - TY - JOUR LB - 96. AU - Micallef, JM AU - Kaldor, JM AU - Dore, GJ TI - Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies J2 - J Viral Hepat PY - 2006 VL - 13 SP - 34 EP - 41 UR - https://doi.org/10.1111/j.1365-2893.2005.00651.x ER - TY - JOUR LB - 97. AU - Kemp, PA AU - Neale, J AU - Robertson, M TI - Homelessness among problem drug users: prevalence, risk factors and trigger events J2 - Health Soc Care Community PY - 2006 VL - 14 SP - 319 EP - 328 UR - https://doi.org/10.1111/j.1365-2524.2006.00624.x ER - TY - JOUR LB - 98. AU - Cornish, R AU - Macleod, J AU - Strang, J AU - Vickerman, P AU - Hickman, M TI - Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database J2 - BMJ PY - 2010 VL - 341 SP - c5475 UR - http://dx.doi.org/10.1136/bmj.c5475 ER - TY - JOUR LB - 99. AU - Martin, NK AU - Foster, GR AU - Vilar, J AU - Ryder, S AU - Cramp, ME AU - Gordon, F TI - HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact J2 - J Viral Hepat PY - 2015 VL - 22 SP - 399 EP - 408 UR - http://dx.doi.org/10.1111/jvh.12338 ER - TY - JOUR LB - 100. AU - Harris, RJ AU - Thomas, B AU - Griffiths, J AU - Costella, A AU - Chapman, R AU - Ramsay, M TI - Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios J2 - J Hepatol PY - 2014 VL - 61 SP - 530 EP - 537 UR - http://dx.doi.org/10.1016/j.jhep.2014.05.008 ER - TY - JOUR LB - 101. AU - Smith, DJ AU - Combellick, J AU - Jordan, AE AU - Hagan, H TI - Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID): a systematic review and meta-analysis J2 - Int J Drug Policy PY - 2015 VL - 26 SP - 911 EP - 921 UR - http://dx.doi.org/10.1016/j.drugpo.2015.07.004 ER - TY - JOUR LB - 102. AU - van der Meer, AJ AU - Veldt, BJ AU - Feld, JJ AU - Wedemeyer, H AU - Dufour, JF AU - Lammert, F TI - Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis J2 - JAMA PY - 2012 VL - 308 SP - 2584 EP - 2593 UR - http://dx.doi.org/10.1001/jama.2012.144878 ER - TY - JOUR LB - 103. AU - Kohli, A AU - Shaffer, A AU - Sherman, A AU - Kottilil, S TI - Treatment of hepatitis C: a systematic review J2 - JAMA PY - 2014 VL - 312 SP - 631 EP - 640 UR - http://dx.doi.org/10.1001/jama.2014.7085 ER - TY - JOUR LB - 104. AU - Jones, HE AU - Welton, NJ AU - Ades, AE AU - Pierce, M AU - Davies, W AU - Coleman, B TI - Problem drug use prevalence estimation revisited: heterogeneity in capture–recapture and the role of external evidence J2 - Addiction PY - 2016 VL - 111 SP - 438 EP - 447 UR - https://doi.org/10.1111/add.13222 ER - TY - BOOK LB - 105. AU - Hay, G AU - Gannon, M AU - MacDougall, J AU - Millar, T AU - Eastwood, C AU - McKeganey, N TI - National and Regional Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use 2006/07: A Summary of Key Findings CY - London PB - Home Office PY - 2008 ER - TY - BOOK LB - 106. AU - Hay, G AU - Rael dos Santos, A AU - Millar, T TI - Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2010/11: Sweep 7 Report CY - London PB - Centre for Public Health, Liverpool John Moores University PY - 2013 ER - TY - JOUR LB - 107. AU - King, R AU - Bird, SM AU - Overstall, A AU - Hay, G AU - Hutchinson, SJ TI - Injecting drug users in Scotland, 2006: listing, number, demography, and opiate-related death-rates J2 - Addict Res Theory PY - 2013 VL - 21 SP - 235 EP - 246 UR - http://dx.doi.org/10.3109/16066359.2012.706344 ER - TY - JOUR LB - 108. AU - Hickman, M AU - Hope, V AU - Coleman, B AU - Parry, J AU - Telfer, M AU - Twigger, J TI - Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action J2 - J Public Health PY - 2009 VL - 31 SP - 374 EP - 382 UR - http://dx.doi.org/10.1093/pubmed/fdp067 ER - TY - BOOK LB - 109. AU - Briggs, A AU - Claxton, K AU - Sculpher, MJ TI - Decision Modelling for Health Economic Evaluation CY - Oxford PB - Oxford University Press PY - 2006 ER - TY - JOUR LB - 110. AU - Xia, Y AU - Seaman, S AU - Hickman, M AU - Macleod, J AU - Robertson, R AU - Copeland, L TI - Factors affecting repeated cessations of injecting drug use and relapses during the entire injecting career among the Edinburgh Addiction Cohort J2 - Drug Alcohol Depend PY - 2015 VL - 151 SP - 76 EP - 83 UR - http://dx.doi.org/10.1016/j.drugalcdep.2015.03.005 ER - TY - JOUR LB - 111. AU - Allen, EJ AU - Palmateer, NE AU - Hutchinson, SJ AU - Cameron, S AU - Goldberg, DJ AU - Taylor, A TI - Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland J2 - Int J Drug Policy PY - 2012 VL - 23 SP - 346 EP - 352 UR - http://dx.doi.org/10.1016/j.drugpo.2012.07.006 ER - TY - JOUR LB - 112. AU - Vickerman, P AU - Hickman, M AU - Judd, A TI - Modelling the impact on hepatitis C transmission of reducing syringe sharing: London case study J2 - Int J Epidemiol PY - 2007 VL - 36 SP - 396 EP - 405 UR - https://doi.org/10.1093/ije/dyl276 ER - TY - JOUR LB - 113. AU - Vickerman, P AU - Platt, L AU - Hawkes, S TI - Modelling the transmission of HIV and HCV among injecting drug users in Rawalpindi, a low HCV prevalence setting in Pakistan J2 - Sex Transm Infect PY - 2009 VL - 85 IS - Suppl. 2 SP - 23 EP - 30 UR - http://dx.doi.org/10.1136/sti.2008.034660 ER - TY - JOUR LB - 114. AU - Martin, NK AU - Vickerman, P AU - Grebely, J AU - Hellard, M AU - Hutchinson, SJ AU - Lima, VD TI - Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals J2 - Hepatology PY - 2013 VL - 58 SP - 1598 EP - 1609 UR - http://dx.doi.org/10.1002/hep.26431 ER - TY - BOOK LB - 115. AU - WHO TI - Draft Global Health Sector Strategy on Viral Hepatitis, 2016–2021 – The First of its Kind CY - Geneva PB - WHO PY - 2015 ER - TY - JOUR LB - 116. AU - Claxton, K AU - Martin, S AU - Soares, M AU - Rice, N AU - Spackman, E AU - Hinde, S TI - Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold J2 - Health Technol Assess PY - 2015 VL - 19 IS - 14 UR - http://dx.doi.org/10.3310/hta19140 ER - TY - JOUR LB - 117. AU - Remme, M AU - Vassall, A AU - Lutz, B AU - Luna, J AU - Watts, C TI - Financing structural interventions: going beyond HIV-only value for money assessments J2 - AIDS PY - 2014 VL - 28 SP - 425 EP - 434 UR - http://dx.doi.org/10.1097/QAD.0000000000000076 ER - TY - BOOK LB - 118. AU - Public Health England TI - Drug Treatment in England 2013–2014 CY - London PB - Public Health England PY - 2014 ER - TY - BOOK LB - 119. AU - Welsh Government TI - Substance Misuse Treatment Framework (SMTF) Recovery Oriented Integrated Systems of Care CY - Cardiff PB - Welsh Government PY - 2013 ER - TY - JOUR LB - 120. AU - Strathdee, SA AU - Patrick, DM AU - Currie, SL AU - Cornelisse, PG AU - Rekart, ML AU - Montaner, JS TI - Needle exchange is not enough: lessons from the Vancouver injecting drug use study J2 - AIDS PY - 1997 VL - 11 SP - F59 EP - F65 UR - https://doi.org/10.1097/00002030-199708000-00001 ER - TY - JOUR LB - 121. AU - Hickman, M AU - Hope, V AU - Brady, T AU - Madden, P AU - Jones, S AU - Honor, S TI - Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004 J2 - J Viral Hepat PY - 2007 VL - 14 SP - 645 EP - 652 UR - https://doi.org/10.1111/j.1365-2893.2007.00855.x ER - TY - BOOK LB - 122. AU - Personal Social Services and Research Unit (PSSRU) TI - Unit Costs of Health and Social Care 2013 CY - Canterbury PB - PSSRU, University of Kent PY - 2013 ER - TY - JOUR LB - 123. AU - Wright, M AU - Forton, D AU - Main, J AU - Goldin, R AU - Torok, E AU - Tedder, R TI - Treatment of histologically mild hepatitis C virus infection with interferon and ribavirin: a multicentre randomized controlled trial J2 - J Viral Hepat PY - 2005 VL - 12 SP - 58 EP - 66 UR - https://doi.org/10.1111/j.1365-2893.2005.00575.x ER - TY - JOUR LB - 124. AU - Martin, NK AU - Vickerman, P AU - Dore, GJ AU - Hickman, M TI - How should HCV treatment be prioritized in the direct-acting antiviral era? An economic evaluation including population prevention benefits J2 - J Hepatol PY - 2016 VL - 65 IS - Suppl. 1 SP - 17 EP - 25 ER -